The cAMP-PKA pathway acts to suppress the activation of p38 MAPK, ERK1/2, and JNK, causing a reduction in AP-1- and C/EBP-mediated transcription, which helps to alleviate IgG-IC-associated acute lung injury [21]. Here, CEBPA is linked to injury.